CHUL
2705, boulevard Laurier
R0-709
Québec, Québec
Canada G1V 4G2
2705, boulevard Laurier
R0-709
Québec, Québec
Canada G1V 4G2
Dernières nouvelles
Mortality in hepatitis C virus-infected patients with a diagnosis of AIDS in the era of combination antiretroviral therapy
Article de revueClin Infect Dis, 55 (1), 2012.
Hepatobiliary Manifestations of Human Immunodeficiency Virus(HIV)
Chapitre de livreSchiff ER, Maddrey WC, Sorrell MF, Schiff L (Ed.): Schiff's diseases of the liver, p. 1060-1082, Chichester, West Sussex, John Wiley & Sons, 2011, ISBN: 9781119950509.
The HIV/HCV-coinfected patient and new treatment options
Article de revueClin Liver Dis, 15 (3), 2011.
The era of direct-acting antivirals has begun: the beginning of the end for HCV?
Article de revueSemin Liver Dis, 31 (4), 2011.
Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-α-2a and ribavirin in HIV/HCV co-infected patients
Article de revueJ Hepatol, 54 (1), 2011.
Signaler des ajouts ou des modifications
Projets actifs
- Optimiser le dépistage des populations vulnérables par goutte de sang séché, du 2022-01-15 au 2024-10-15
- Optimization of a live microneutralization assay to evaluate antibody levels against mpox in vaccinated or infected individuals in Quebec, du 2023-04-24 au 2024-04-23
Projets terminés récemment
- After the Cure: Measuring the full impacts of direct acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada, du 2022-10-01 au 2023-03-31
- Surveillance des réponses immunitaires au vaccin contre la COVID-19 chez les personnes vivant avec le VIH-1, du 2021-12-01 au 2022-11-30
- The National CIHR Hepatisis C Network (NCHCN), du 2015-04-01 au 2021-10-31